These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11252789)

  • 1. Set of vectors for the expression of histidine-tagged proteins in vaccinia virus recombinants.
    Galindo I; Lorenzo MM; Blasco R
    Biotechniques; 2001 Mar; 30(3):524-6, 528-9. PubMed ID: 11252789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of vaccinia MVA recombinants using the viral F13L gene as the selective marker.
    Sánchez-Puig JM; Blasco R
    Biotechniques; 2005 Nov; 39(5):665-6, 668, 670 passim. PubMed ID: 16312215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel vaccinia virus expression system allowing construction of recombinants without the need for selection markers, plasmids and bacterial hosts.
    Pfleiderer M; Falkner FG; Dorner F
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():2957-62. PubMed ID: 8847500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus.
    Janknecht R; de Martynoff G; Lou J; Hipskind RA; Nordheim A; Stunnenberg HG
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):8972-6. PubMed ID: 1924358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient and inducible expression of vaccinia/T7 recombinant viruses.
    Mohamed MR; Niles EG
    Methods Mol Biol; 2004; 269():41-50. PubMed ID: 15114006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and characterization of vaccinia direct ligation vectors.
    Merchlinsky M; Eckert D; Smith E; Zauderer M
    Virology; 1997 Nov; 238(2):444-51. PubMed ID: 9400616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BiZyme: a novel fusion protein-mediating selection of vaccinia virus recombinants by fluorescence and antibiotic resistance.
    Hansen SG; Cope TA; Hruby DE
    Biotechniques; 2002 May; 32(5):1178, 1180, 1182-7. PubMed ID: 12019792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host range selection of vaccinia recombinants containing insertions of foreign genes into non-coding sequences.
    Smith KA; Stallard V; Roos JM; Hart C; Cormier N; Cohen LK; Roberts BE; Payne LG
    Vaccine; 1993; 11(1):43-53. PubMed ID: 8427036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible gene expression from vaccinia virus vectors.
    Rodriguez JF; Smith GL
    Virology; 1990 Jul; 177(1):239-50. PubMed ID: 2191497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compact, synthetic, vaccinia virus early/late promoter for protein expression.
    Chakrabarti S; Sisler JR; Moss B
    Biotechniques; 1997 Dec; 23(6):1094-7. PubMed ID: 9421642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.
    Mackett M; Smith GL; Moss B
    J Virol; 1984 Mar; 49(3):857-64. PubMed ID: 6321770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple-cloning-site plasmids for the rapid construction of recombinant poxviruses.
    Boyle DB; Coupar BE; Both GW
    Gene; 1985; 35(1-2):169-77. PubMed ID: 4029620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors.
    Falkner FG; Moss B
    J Virol; 1988 Jun; 62(6):1849-54. PubMed ID: 3130492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian cell/vaccinia virus expression vectors with increased stability of retroviral sequences in Escherichia coli: production of feline immunodeficiency virus envelope protein.
    Wang RF; Mullins JI
    Gene; 1995 Feb; 153(2):197-202. PubMed ID: 7875588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and isolation of recombinant vaccinia virus using genetic markers.
    Lorenzo MM; Galindo I; Blasco R
    Methods Mol Biol; 2004; 269():15-30. PubMed ID: 15114004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new vaccinia recombinant plasmid pSC-O.
    Scheiflinger F; Bodemer W
    Gene; 1991 Dec; 109(2):307-8. PubMed ID: 1765277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a novel set of transfer vectors to study vaccinia virus replication and foreign gene expression.
    Dvoracek B; Shors T
    Plasmid; 2003 Jan; 49(1):9-17. PubMed ID: 12583996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.
    Jewell JE; Ball LA; Rueckert R
    J Virol; 1990 Mar; 64(3):1388-93. PubMed ID: 2154618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of recombinant MVA using F13L selection.
    Sánchez-Puig JM; Lorenzo MM; Blasco R
    Methods Mol Biol; 2012; 890():93-111. PubMed ID: 22688762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological and immunological characterization of influenza virus haemagglutinin expressed from the haemagglutinin locus of vaccinia virus.
    Itamura S; Morikawa Y; Shida H; Nerome K; Oya A
    J Gen Virol; 1990 Jun; 71 ( Pt 6)():1293-301. PubMed ID: 2351957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.